ArticleJournal of Cancer2025

Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis.

Lingbin Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.